We will be delving into the science behind Valeda light therapy for treating age-related macular degeneration (AMD).
In this session, we’ll be joined Professor Tim Jackson, consultant ophthalmic surgeon from King’s College Hospital, to explore the science behind the Valeda photobiomodulation technique. The therapy uses three wavelengths of light to stimulate the layer of cells in the back of the eye called the retinal pigment epithelium (RPE), to keep them healthy for longer.
Professor Jackson will also discuss the data from the LIGHTSITE III clinical trial in more detail. The small study on 100 participants, with early and intermediate dry AMD, aimed to assess the impact of the therapy on visual outcomes and early changes to the back to the eye, as well as the development of late-stage dry AMD, known as geographic atrophy (GA).
Please share any questions you would like our guests to address in our upcoming webinars. Send them to mymacularandme@macularsociety.org
This webinar will be taking place on Tuesday 21 May at 7pm.
To register for the webinar use the link below
us02web.zoom.us/webinar/reg...
Our webinars are also posted on our website a few days after the live event. Please refer to the link below
macularsociety.org/support/...
Best wishes,
Carol
Macular Society Helpline
Early AMD and epimacular membrane
Referred to Eye Infirmary for wet AMD ......
re wet and dry amd
"Virtual" assessments for AMD
